Maine CDC Information

• Program Index
• Conferences & Events
• Healthy Maine 2010
• Health Profiles
• Influenza 2009-2010
• Health Indicator Comparison Tables
• Pandemic Influenza Info
• Public Health Data Reports
• Reports, Publications and Newsletters

District Public Health

• Office of Local Public Health
• Local Public Health Districts
• Statewide Coordinating Council
• Rural Health and Primary Care

Info for Health Providers

• Public Health Advisories
• Disease-Specific Information
• Disease Reporting
  1-800-821-5821

Influenza Vaccine

Information for Providers

Priority Groups | Distribution | Supply | Private Purchase

In the United States, influenza morbidity and mortality are reduced through the use of vaccine. Vaccinating persons at high risk for complications and their contacts each year before seasonal influenza begins to circulate is the most effective method of reducing the effects of influenza. Healthcare providers play a role to ensure vaccine is administered to persons during hospitalizations or routine healthcare visits, making special office or clinic visits unnecessary.

Maine CDC's vaccine supply is determined in collaboration with federal partners. National vaccine supplies rely upon manufacturers' projected vaccine production and federal licensing regulations. Maine CDC does not anticipate a vaccine shortage this year. Four manufacturers are currently licensed to provide inactivated (injectable) vaccine, and another is licensed to provide nasal flu vaccine (Flu Mist).

Resources:

• http://www.preventinfluenza.org

Maine.gov | DHHS Home | Site Policies | Language Access | Comments/Questions